Skip to main content

Table 3 Sample size calculation

From: Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial

Significance level (α)

0.05

Power (1-β)

0.80

Hazard Ratio (HR), θ (non-inferiority margin)

1.3

Null-Hypothesis Hazard Ratio, θ0

1.0

Recruitment time/study accrual (months)

36

Follow-up time (months)

60

Ratio control vs. experimental: m2/m1

1.0

Total sample size (NS)/total number to be randomized (NR)

599

Accounting for 3% loss to follow-up after randomization (NLTFU)

18

Accounting for 10% drop-out ratio pre-randomization (NDO)

69

Initial pre-randomization sample size – number of included patients (NI)

687